VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 86 filers reported holding VERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $249,782 | -14.6% | 18,219 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $292,415 | +324.3% | 18,219 | +105.1% | 0.00% | +100.0% |
| Q1 2023 | $68,916 | -59.9% | 8,881 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $171,847 | -9.2% | 8,881 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $189,254 | +56.6% | 8,881 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $120,870 | -42.1% | 8,881 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $208,615 | – | 8,881 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $40,289,000 | 12.90% |
| Kynam Capital Management, LP | 1,522,712 | $20,724,000 | 5.29% |
| Sofinnova Investments, Inc. | 3,181,442 | $43,299,000 | 3.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,825 | $281,057,000 | 2.93% |
| Octagon Capital Advisors LP | 575,000 | $7,826,000 | 2.09% |
| Vivo Capital, LLC | 666,666 | $9,073,000 | 0.91% |
| RA Capital Management | 1,578,820 | $21,488,000 | 0.57% |
| Alphabet Inc. | 301,580 | $4,105,000 | 0.22% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $219,000 | 0.11% |
| Polar Asset Management Partners Inc. | 294,300 | $4,005,000 | 0.05% |